ArticleBMC ophthalmology2026
Quantitative gonioscopic assessment of anterior chamber angle remodeling using the spaeth classification after Schlemm's canal-based MIGS (3T) in POAG: a one-year retrospective study.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTrabeculotome Tunneling Trabeculoplasty (3T) is a recently developed Schlemm's canal-based minimally invasive glaucoma surgery (MIGS) designed to reconstruct the trabecular meshwork-Schlemm's canal pathway to facilitate aqueous humor outflow, while minimizing disruption to ocular surface structures. Although this procedure is gaining clinical use in China, evidence regarding its long-term efficacy, safety, and anatomical impact remains limited. Few studies have systematically assessed postoperative changes in the anterior chamber angle, which plays a key role in intraocular pressure (IOP) control. This study aimed to evaluate the 1-year outcomes of 3T surgery in patients with primary open-angle glaucoma (POAG), including its effectiveness, safety profile, and angle remodeling assessed via gonioscopic imaging.
methodsThis retrospective study included 25 patients (31 eyes) with primary open-angle glaucoma (POAG) who underwent Trabeculotome Tunneling Trabeculoplasty (3T) at Chengdu Integrated TCM and Western Medicine Hospital, also known as Chengdu First People's Hospital between December 2022 and October 2023. All patients were followed for 12 months. Clinical data including preoperative and postoperative intraocular pressure (IOP), number of anti-glaucoma medications, intra- and postoperative complications, and gonioscopic findings were collected and analyzed to evaluate the 1-year outcomes of the 3T procedure in terms of efficacy, safety, and anterior chamber angle remodeling.
resultsAmong the 25 patients (31 eyes) included in this study. Mean baseline IOP decreased from 24.8 ± 5.7 mmHg preoperatively to 16.8 ± 3.7 mmHg at 12 months (p < 0.001), with medications reduced from 2.6 ± 1.2 to 0.4 ± 0.9 (p < 0.001). The overall success rate was 93.6% (29/31 eyes), including 74.2% complete success and 19.4% qualified success. Complications included transient IOP spikes (51.6%, 16/31 eyes) and hyphema (6.5%, 2/31 eyes). No choroidal detachment, shallow anterior chamber, or other vision-threatening complications were observed. Gonioscopy showed stable iris root insertion and angle width postoperatively (p > 0.05). Pigment deposition and PAS increased in inferior/nasal quadrants postoperatively but stabilized by 3 months (p < 0.05). Trabeculotomy incisions narrowed due to PAS formation but stabilized without compromising IOP reduction. Schlemm's canal tension stitches remained intact at 12 months.
conclusions3T surgery significantly reduced IOP and medication dependence in POAG over 12 months, with transient IOP spikes as the primary complication. Postoperative anterior angle anatomy remained stable, and PAS-related changes in trabeculotomy sites stabilized within 3 months without affecting efficacy. These findings support 3T as a promising minimally invasive approach for POAG, though further validation is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.